Levy, Roger A

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M.-C., Amoura, Z., Andrade, D., Andreoli, L., Artim-Esen, B., et al. (2023) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 493

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan, D., Harrison, M. J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp‐Arida, A., Vilela, V., Yazici, Y., & Lockshin, M. D. (2007) · Arthritis & Rheumatism

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 401

CCL 2, CXCL 8, CXCL 9 and CXCL 10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees

Bonfante, H. D. L., Almeida, C. D. S., Abramo, C., Grunewald, S. T. F., Levy, R. A., & Teixeira, H. C. (2017) · International Journal of Rheumatic Diseases

Osteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and Therapies

Cited by 33